Skip to main content
Erschienen in: Annals of Surgical Oncology 1/2018

13.11.2017 | Breast Oncology

Radioactive Seed Localization Versus Wire Localization for Nonpalpable Breast Lesions: A Two-Year Initial Experience at a Large Community Hospital

verfasst von: Lacey Stelle, MD, Taylor Schoenheit, MD, Allison Brubaker, MD, Xiwei Tang, PhD, Peiyong Qu, PhD, Kimberly Cradock, MD, Anna Higham, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Radioactive seed localization (RSL) is a safe and effective alternative to wire localization (WL) for nonpalpable breast lesions. While several large academic institutions currently utilize RSL, few community hospitals have adopted this technique.

Objective

The aim of this study was to examine the experience of RSL versus WL at a large community hospital.

Methods

A retrospective chart review of patients who underwent RSL or WL for breast-conserving surgery from 1 November 2013 to 31 November 2015.

Results

The total number of lesions examined was 382. RSL was utilized in 205 (54%) lesions, with 187 undergoing single RSL, while WL was used in 155 (40%) lesions, with 109 undergoing single WL; both techniques were used in 22 (6%) lesions. Pathology was benign in 142 (48%) lesions, with 93 RSLs and 49 WLs. For malignant lesions, mean specimen size was 36.3 g for single RSL and 35.9 g for single WL (p = 0.904). Re-excision for margin clearance was required for 16 (17%) malignant lesions in the RSL group and 10 (17%) in the WL group (p = 0.954). For malignant lesions, mean operating room time was 86 min for single RSL versus 70 min for single WL (p = 0.014).

Conclusions

The use of RSL is a viable option in the community setting, with several benefits over WL. While operative times were slightly longer with RSL, there was no difference in specimen size or re-excision rate for malignant lesions.
Literatur
1.
Zurück zum Zitat Haakinson DJ, Stucky CC, Dueck AC, Gray RJ, Wasif N, Apsey HA, Pockaj B. A significant number of women present with palpable breast cancer even with a normal Mammogram within 1 Year. Am J Surg. 2010;200(6):712–7;discussion 717-8. Haakinson DJ, Stucky CC, Dueck AC, Gray RJ, Wasif N, Apsey HA, Pockaj B. A significant number of women present with palpable breast cancer even with a normal Mammogram within 1 Year. Am J Surg. 2010;200(6):712–7;discussion 717-8.
2.
Zurück zum Zitat Acosta JA, Greenlee JA, Gubler KD, Goepfert CJ, Ragland JJ. Surgical margins after needle-localization breast biopsy. Am J Surg. 1995;170(6):643–6.CrossRefPubMed Acosta JA, Greenlee JA, Gubler KD, Goepfert CJ, Ragland JJ. Surgical margins after needle-localization breast biopsy. Am J Surg. 1995;170(6):643–6.CrossRefPubMed
3.
Zurück zum Zitat Frank HA, Hall FM, Steer ML. Preoperative localization of nonpalpable breast lesions demonstrated by mammography. N Engl J Med. 1976;295(5):259–260.CrossRefPubMed Frank HA, Hall FM, Steer ML. Preoperative localization of nonpalpable breast lesions demonstrated by mammography. N Engl J Med. 1976;295(5):259–260.CrossRefPubMed
4.
Zurück zum Zitat Chan BK, Wiseberg-Firtell JA, Jois RH, Jensen K, Audisio RA. Localization techniques for guided surgical excision of non-palpable breast lesions. Cochrane Database Syst Rev. 2015;(12):CD009206. Chan BK, Wiseberg-Firtell JA, Jois RH, Jensen K, Audisio RA. Localization techniques for guided surgical excision of non-palpable breast lesions. Cochrane Database Syst Rev. 2015;(12):CD009206.
5.
Zurück zum Zitat Gray RJ, Salud C, Nguyen K, et al. Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of nonpalpable breast lesions: radioactive seed versus wire localization. Ann Surg Oncol. 2001;8(9):711–5.CrossRefPubMed Gray RJ, Salud C, Nguyen K, et al. Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of nonpalpable breast lesions: radioactive seed versus wire localization. Ann Surg Oncol. 2001;8(9):711–5.CrossRefPubMed
6.
Zurück zum Zitat Dauway EL, Saunders R, Friedland J et al. Innovative diagnostics for breast cancer: new frontiers for the new millennium using radioactive seed localization. Surg Forum. 1999;50:348–9. Dauway EL, Saunders R, Friedland J et al. Innovative diagnostics for breast cancer: new frontiers for the new millennium using radioactive seed localization. Surg Forum. 1999;50:348–9.
7.
Zurück zum Zitat Lovrics PJ, Goldsmith CH, Hodgson N, et al. A multicentered, randomized, controlled trial comparing radioguided seed localization to standard wire localization for nonpalpable, invasive and in situ breast carcinomas. Ann Surg Oncol. 2011;18(12):3407–14.CrossRefPubMed Lovrics PJ, Goldsmith CH, Hodgson N, et al. A multicentered, randomized, controlled trial comparing radioguided seed localization to standard wire localization for nonpalpable, invasive and in situ breast carcinomas. Ann Surg Oncol. 2011;18(12):3407–14.CrossRefPubMed
8.
Zurück zum Zitat Murphy JO, Moo T-A, King TA, et al. Radioactive seed localization compared to wire localization in breast-conserving surgery: initial 6-month experience. Ann Surg Oncol. 2013;20(13):4121–27.CrossRefPubMedPubMedCentral Murphy JO, Moo T-A, King TA, et al. Radioactive seed localization compared to wire localization in breast-conserving surgery: initial 6-month experience. Ann Surg Oncol. 2013;20(13):4121–27.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat McGhan LJ, McKeever SC, Pockaj BA, et al. Radioactive seed localization for nonpalpable beast lesions: review of 1,000 consecutive procedures at a single institution. Ann Surg Oncol. 2011;18(11):3096–101.CrossRefPubMed McGhan LJ, McKeever SC, Pockaj BA, et al. Radioactive seed localization for nonpalpable beast lesions: review of 1,000 consecutive procedures at a single institution. Ann Surg Oncol. 2011;18(11):3096–101.CrossRefPubMed
10.
Zurück zum Zitat Sung JS, King V, Thornton CM, et al. Safety and efficacy of radioactive seed localization with I-125 prior to lumpectomy and/or excisional biopsy. Eur J Radiol. 2013;82(9):1453–57.CrossRefPubMed Sung JS, King V, Thornton CM, et al. Safety and efficacy of radioactive seed localization with I-125 prior to lumpectomy and/or excisional biopsy. Eur J Radiol. 2013;82(9):1453–57.CrossRefPubMed
11.
Zurück zum Zitat Ahmed M. Radioactive seed localization for non-palpable breast cancer. Br J Surg. 2013;100(9):1253.CrossRefPubMed Ahmed M. Radioactive seed localization for non-palpable breast cancer. Br J Surg. 2013;100(9):1253.CrossRefPubMed
12.
Zurück zum Zitat Jakub J, Gray R. Starting a radioactive seed localization program. Ann Surg Oncol. 2015;22(10):3197–202.CrossRefPubMed Jakub J, Gray R. Starting a radioactive seed localization program. Ann Surg Oncol. 2015;22(10):3197–202.CrossRefPubMed
13.
Zurück zum Zitat Chiu JC, Ajmal S, Zhu X, Griffith E, Encarnacion T, Barr L. Radioactive seed localization of nonpalpable breast lesions in an academic comprehensive cancer program community hospital setting. Am Surg. 2014;80(7):675–9.PubMed Chiu JC, Ajmal S, Zhu X, Griffith E, Encarnacion T, Barr L. Radioactive seed localization of nonpalpable breast lesions in an academic comprehensive cancer program community hospital setting. Am Surg. 2014;80(7):675–9.PubMed
14.
Zurück zum Zitat Diego EJ, Soran A, McGuire KP, et al. Localizing high-risk lesions for excisional breast biopsy: a comparison between radioactive seed localization and wire localization. Ann Surg Oncol. 2014;21(10):3268–72.CrossRefPubMed Diego EJ, Soran A, McGuire KP, et al. Localizing high-risk lesions for excisional breast biopsy: a comparison between radioactive seed localization and wire localization. Ann Surg Oncol. 2014;21(10):3268–72.CrossRefPubMed
15.
Zurück zum Zitat van der Noordaa MEM, Pengel KE, Groen E, et al. The use of radioactive Iodine-125 seed localization in patients with non-palpable breast cancer: a comparison with the radioguided occult lesion localization with 99m Technetium. Eur J Surg Oncol. 2015;41(4):553–8.CrossRefPubMed van der Noordaa MEM, Pengel KE, Groen E, et al. The use of radioactive Iodine-125 seed localization in patients with non-palpable breast cancer: a comparison with the radioguided occult lesion localization with 99m Technetium. Eur J Surg Oncol. 2015;41(4):553–8.CrossRefPubMed
16.
Zurück zum Zitat Sharek D, Zuley ML, Zhang JY, Soran A, Ahrendt GM, Ganott MA. Radioactive seed localization versus wire localization for lumpectomies: a comparison of outcomes. Am J Roentgenol. 2015;204(4):872–7.CrossRef Sharek D, Zuley ML, Zhang JY, Soran A, Ahrendt GM, Ganott MA. Radioactive seed localization versus wire localization for lumpectomies: a comparison of outcomes. Am J Roentgenol. 2015;204(4):872–7.CrossRef
17.
Zurück zum Zitat Bloomquist EV, Ajkay N, Patil S, Collett AE, Frazier TG, Barrio AV. A randomized prospective comparison of patient-assessed satisfaction and clinical outcomes with radioactive seed localization versus wire localization. Breast J. 2016;22(2):151–7.CrossRefPubMed Bloomquist EV, Ajkay N, Patil S, Collett AE, Frazier TG, Barrio AV. A randomized prospective comparison of patient-assessed satisfaction and clinical outcomes with radioactive seed localization versus wire localization. Breast J. 2016;22(2):151–7.CrossRefPubMed
18.
Zurück zum Zitat Pouw B, de Wit-van der Veen LJ, Stokkel MP, Loo CE, Vrancken Peeters MJ, Valdés Olmos RA. Heading toward radioactive seed localization in non-palpable breast cancer surgery? A meta-analysis. J Surg Oncol. 2015;111(2):185–91. Pouw B, de Wit-van der Veen LJ, Stokkel MP, Loo CE, Vrancken Peeters MJ, Valdés Olmos RA. Heading toward radioactive seed localization in non-palpable breast cancer surgery? A meta-analysis. J Surg Oncol. 2015;111(2):185–91.
19.
Zurück zum Zitat Janssen NNY, Nijkamp J, Alderliesten T, et al. Radioactive seed localization in breast cancer treatment. Br J Surg. 2016;103(1):70–80.CrossRefPubMed Janssen NNY, Nijkamp J, Alderliesten T, et al. Radioactive seed localization in breast cancer treatment. Br J Surg. 2016;103(1):70–80.CrossRefPubMed
20.
Zurück zum Zitat Papa MZ, Klein E, Davidson B, et al. The effect of anesthesia type on needle localization breast biopsy: another point of view. Am J Surg. 1996;171(2):242–43.CrossRefPubMed Papa MZ, Klein E, Davidson B, et al. The effect of anesthesia type on needle localization breast biopsy: another point of view. Am J Surg. 1996;171(2):242–43.CrossRefPubMed
21.
Zurück zum Zitat Gajdos C, Tartter PI, Bleiweiss IJ, et al. Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics. Ann Surg. 2002;235(2):246–51.CrossRefPubMedPubMedCentral Gajdos C, Tartter PI, Bleiweiss IJ, et al. Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics. Ann Surg. 2002;235(2):246–51.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Lovrics PJ, Cornacchi SD, Vora R, Goldsmith CH, Kahnamoui K. Systematic review of radioguided surgery for non-palpable breast cancer. Eur J Surg Oncol. 2011;37(5):388–97.CrossRefPubMed Lovrics PJ, Cornacchi SD, Vora R, Goldsmith CH, Kahnamoui K. Systematic review of radioguided surgery for non-palpable breast cancer. Eur J Surg Oncol. 2011;37(5):388–97.CrossRefPubMed
23.
Zurück zum Zitat Chagpar AB, Killelea BK, Tsangaris TN, et al. A randomized, controlled trial of cavity shave margins in breast cancer. N Engl J Med. 2015;373(6):503–10.CrossRefPubMedPubMedCentral Chagpar AB, Killelea BK, Tsangaris TN, et al. A randomized, controlled trial of cavity shave margins in breast cancer. N Engl J Med. 2015;373(6):503–10.CrossRefPubMedPubMedCentral
Metadaten
Titel
Radioactive Seed Localization Versus Wire Localization for Nonpalpable Breast Lesions: A Two-Year Initial Experience at a Large Community Hospital
verfasst von
Lacey Stelle, MD
Taylor Schoenheit, MD
Allison Brubaker, MD
Xiwei Tang, PhD
Peiyong Qu, PhD
Kimberly Cradock, MD
Anna Higham, MD
Publikationsdatum
13.11.2017
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 1/2018
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-017-6102-1

Weitere Artikel der Ausgabe 1/2018

Annals of Surgical Oncology 1/2018 Zur Ausgabe

Health Services Research and Global Oncology

The Annals of Surgical Oncology: An Oncology Journal for Surgeons

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.